Error: Could not add to watchlist. X
+ Watchlist

Amicus Therapeutics Inc

FOLD:US
NASDAQ GM
14.24
USD
0.40
2.73%
As of 10/18/2017
Open
14.63
Day Range
14.19 - 14.79
Volume
1,558,684
Previous Close
14.64
52Wk Range
4.41 - 16.60
1 Yr Return
99.16%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
14.63
Day Range
14.19 - 14.79
Volume
1,558,684
Previous Close
14.64
52Wk Range
4.41 - 16.60
1 Yr Return
99.16%
YTD Return
186.52%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.39
Market Cap (b USD)
2.343
Shares Outstanding (m)
164.566
Price/Sales (TTM)
124.67
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.16%
% Price Change
-0.17%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
Address
1 Cedar Brook Drive
Cranbury, NJ 08512
United States
Phone
1-609-662-2000
Show More